Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

On May 9, 2025, the U.S. Food and Drug Administration (FDA) granted three color additive petitions, approving two new ...

President Donald Trump’s push to lower pharmaceutical prices by buying more drugs from abroad likely won’t work and may not ...

The Trump plan won't be limited to Medicare prescriptions and will also target medications covered by Medicaid and private ...

The US Food and Drug Administration has approved three new color additives from natural sources “that will expand the palette ...

The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...